2011•Clinical Lymphoma Myeloma & LeukemiaRequires access

5.9 Bendamustine and Alemtuzumab Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia: Interim Report of the Italian Trial

Alessandra Tedeschi, Marta Coscia, Davide Rossi, Francesca Ricci, Giovanni D’Arena, Ester Orlandi, Valeria Belsito Petrizzi, Lydia Scarfò, Candida Vitale, Eleonora Vismara, Gianluca Gaïdano, Enrica Morra, Massimo Massaia, Marco Montillo

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bendamustine, Alemtuzumab, Chronic lymphocytic leukemia, Medicine, Refractory (planetary science), Interim, Leukemia, Oncology